Grimm P C, McKenna R M, Gospodarek E M, Jeffery J R, Rush D N
Department of Pediatrics, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Transplantation. 1995 Feb 27;59(4):579-84.
Immunosuppressive drugs used in clinical transplantation block cytokine mRNA transcription in vitro, but clinical rejection episodes are common. An understanding of what cytokine message is transcribed would be helpful in determining what contributes to the success of immunosuppression and provide directions for further research aimed at targeting specific cytokines. Previous studies have examined cytokine mRNA in rejecting solid organ biopsies by the reverse transcriptase polymerase chain reaction (RT-PCR) with variable results. We used nonradioactive in situ hybridization with cytokine-specific riboprobes to determine the frequency of cells expressing cytokine mRNA in the allograft infiltrate. Kidney biopsies were obtained from patients receiving protocol biopsies and with clinical evidence of rejection. Fourteen biopsies with a pathologic diagnosis of rejection were studied. Eight showed no cytokine staining, 2 expressed IL-2, and 3 expressed IL-4 and IFN-gamma. The positive cells were present at a low frequency (mean 2, range 1-5 per 10 high-power fields). The proportion of kidney biopsies expressing detectable message for interleukin-2 (IL-2), interleukin-4 (IL-4), and interferon-gamma (IFN-gamma) by in situ hybridization were similar to those reported using RT-PCR. The novel finding is that these cytokines are expressed in a few strongly positive cells in the allograft infiltrate. The vast majority of infiltrating cells are negative. This suggests that either the biopsies were performed when cytokine message was not expressed at a high level or that in human allograft recipients the sustained expression of the cytokines IL-2, IL-4, and IFN-gamma may not be necessary for graft rejection.
临床移植中使用的免疫抑制药物在体外可阻断细胞因子mRNA转录,但临床排斥反应仍很常见。了解转录了哪些细胞因子信息将有助于确定免疫抑制成功的因素,并为针对特定细胞因子的进一步研究提供方向。以往研究通过逆转录聚合酶链反应(RT-PCR)检测排斥性实体器官活检中的细胞因子mRNA,结果各异。我们使用细胞因子特异性核糖探针进行非放射性原位杂交,以确定同种异体移植物浸润中表达细胞因子mRNA的细胞频率。从接受方案活检且有临床排斥证据的患者中获取肾活检样本。对14例病理诊断为排斥的活检样本进行了研究。8例未显示细胞因子染色,2例表达IL-2,3例表达IL-4和IFN-γ。阳性细胞频率较低(平均每10个高倍视野2个,范围为1-5个)。通过原位杂交检测到表达白细胞介素-2(IL-2)、白细胞介素-4(IL-4)和干扰素-γ(IFN-γ)可检测信息的肾活检样本比例与使用RT-PCR报告的比例相似。新发现是这些细胞因子在同种异体移植物浸润中的少数强阳性细胞中表达。绝大多数浸润细胞为阴性。这表明要么活检是在细胞因子信息未高水平表达时进行的,要么在人类同种异体移植受者中,细胞因子IL-2、IL-4和IFN-γ的持续表达可能不是移植物排斥所必需的。